Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U1 small nuclear 72, pseudogene (RNU1-72P)** is a genomic sequence classified as a pseudogene, related to the U1 small nuclear RNA gene family. U1 snRNA is a component of the spliceosome complex essential for pre-mRNA splicing, but pseudogenes like RNU1-72P are generally considered non-functional copies generated during evolution, containing mutations or structural changes that prevent them from encoding a functional RNA or protein. While some recent evidence suggests that certain pseudogenes of U1 snRNA may still be transcriptionally active and potentially produce variant snRNAs with possible roles in the regulation of gene expression, there is currently no direct evidence that RNU1-72P encodes a functional molecule or plays a role in disease or therapy[2][1]. Thus, RNU1-72P is not considered a therapeutic target or a biologically active receptor, enzyme, or other molecular target, and its function, if any, remains uncharacterized. **Additional context:** - The canonical, functional U1 snRNA genes (e.g., RNU1-1, RNU1-2) are essential for spliceosome activity, but RNU1-72P is classified as a pseudogene because it is an incomplete or imperfect copy that does not encode a functional snRNA[2]. - Some pseudogenes within this family can be transcriptionally active, but whether RNU1-72P itself produces a functional transcript is unknown[2]. - No diseases, drugs, or biomarkers are associated with RNU1-72P; it lacks known therapeutic, clinical, or mechanistic relevance[1]. - As a pseudogene, RNU1-72P does not belong to classical protein or receptor families, but rather to the non-coding, processed pseudogene class[1][2]. **Note:** If "RNU1-72P" was intended to denote a canonical U1 snRNA, as in RNU1-1, distinct structured data would be appropriate, but the available evidence indicates that RNU1-72P specifically refers to a non-functional pseudogene[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 72, pseudogene (RNU1-72P).